BNTX - BioNTech/ Genmab lung cancer therapy improves survival with Keytruda
2024-06-01 13:30:00 ET
More on BioNTech
- BioNTech SE 2024 Q1 - Results - Earnings Call Presentation
- BioNTech SE (BNTX) Q1 2024 Earnings Call Transcript
- BioNTech: Undecided Between A One Trick Pony And A Full-Fledged Pharma Company
- BioNTech gains antibody drug conjugate platform license from Chinese biotech
- New COVID FLiRT variants spike as FDA delays key vaccine meeting